Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-26

Clinical Trial Update: Clinical Efficacy of Ustekinumab in Crohn's Disease

View source ↗

Summary

This document provides an update on a clinical trial evaluating the efficacy of ustekinumab in Crohn's disease, which is currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Kazakhstan Scientific Society for Study of intestine diseases | Conditions: Crohn's Disease | Status: RECRUITING